Quantitative MRI Volumetry as a Potential Neuroimaging Biomarker in Levetiracetam-Treated Epilepsy

Sibel Çıplak, Serkan Ünlü

Open source

DOI
10.3390/diagnostics16183013
Published
2026-09-17
Container
Diagnostics
Publisher
MDPI AG
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/diagnostics16183013,
  title = {Quantitative MRI Volumetry as a Potential Neuroimaging Biomarker in Levetiracetam-Treated Epilepsy},
  author = {Sibel Çıplak and Serkan Ünlü},
  year = {2026},
  journal = {Diagnostics},
  doi = {10.3390/diagnostics16183013},
  url = {https://doi.org/10.3390/diagnostics16183013}
}

RIS

TY  - JOUR
TI  - Quantitative MRI Volumetry as a Potential Neuroimaging Biomarker in Levetiracetam-Treated Epilepsy
AU  - Sibel Çıplak
AU  - Serkan Ünlü
PY  - 2026
JO  - Diagnostics
DO  - 10.3390/diagnostics16183013
UR  - https://doi.org/10.3390/diagnostics16183013
ER  - 

APA

Çıplak, S., & Ünlü, S. (2026). Quantitative MRI Volumetry as a Potential Neuroimaging Biomarker in Levetiracetam-Treated Epilepsy. Diagnostics. https://doi.org/10.3390/diagnostics16183013

Source records